111 related articles for article (PubMed ID: 22704582)
1. Bisphosphonates in early breast cancer.
Dubsky P; Bartsch R
Lancet Oncol; 2012 Jul; 13(7):660-1. PubMed ID: 22704582
[No Abstract] [Full Text] [Related]
2. Bisphosphonates: are they standard of care for the treatment of breast cancer?
Pritchard KI
Br J Cancer; 2007 Jun; 96(12):1781-2. PubMed ID: 17565339
[No Abstract] [Full Text] [Related]
3. Bisphosphonates in adjuvant treatment of early breast cancer.
; Harbeck N; von Minckwitz G; Thürlimann B
Crit Rev Oncol Hematol; 2010 Apr; 74 Suppl 1():S1. PubMed ID: 20427026
[No Abstract] [Full Text] [Related]
4. Adjuvant bisphosphonates in patients with breast cancer: does the potency matter?
Amoroso V; Petrelli F; Pedersini R; Simoncini EL; Clézardin P; Barni S; Berruti A
Future Oncol; 2015; 11(21):2853-6. PubMed ID: 26403833
[No Abstract] [Full Text] [Related]
5. Routine adjuvant use of bisphosphonates in breast cancer arguments in favour and against.
Diel I; Aebi S
Crit Rev Oncol Hematol; 2010 Apr; 74 Suppl 1():S11-5. PubMed ID: 20427027
[No Abstract] [Full Text] [Related]
6. Bisphosphonates in the adjuvant treatment of breast cancer.
Winter MC; Coleman RE
Clin Oncol (R Coll Radiol); 2013 Feb; 25(2):135-45. PubMed ID: 23207072
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates and breast cancer incidence and recurrence.
Chlebowski RT; Col N
Breast Dis; 2011; 33(2):93-101. PubMed ID: 22142660
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates as anticancer therapy for early breast cancer.
Mahtani R; Jahanzeb M
Clin Breast Cancer; 2010 Oct; 10(5):359-66. PubMed ID: 20920980
[TBL] [Abstract][Full Text] [Related]
9. Clodronate in the prevention and treatment of skeletal metastasis.
Gulley J; Dahut WL
Expert Rev Anticancer Ther; 2005 Apr; 5(2):221-30. PubMed ID: 15877520
[TBL] [Abstract][Full Text] [Related]
10. [Bisphosphonates for osseus invasion caused by bronchial carcinoma].
Bartl R
Dtsch Med Wochenschr; 2008 Nov; 133(48):2530. PubMed ID: 19021088
[No Abstract] [Full Text] [Related]
11. Utilization of palliative radiotherapy for breast cancer patients with bone metastases treated with bisphosphonates-Toronto Sunnybrook Regional Cancer Centre experience.
Enright K; Clemons M; Chow E
Support Care Cancer; 2004 Jan; 12(1):48-52. PubMed ID: 14577020
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonates as adjuvant treatment for breast cancer.
Gralow JR
BMJ; 2002 Nov; 325(7372):1051-2. PubMed ID: 12424151
[No Abstract] [Full Text] [Related]
13. Postmenopausal osteoporosis. The role of intravenous bisphosphonates.
Kessenich C
Adv Nurse Pract; 2008 Nov; 16(11):59-62. PubMed ID: 19999059
[No Abstract] [Full Text] [Related]
14. Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026].
Powles T; Paterson A; McCloskey E; Schein P; Scheffler B; Tidy A; Ashley S; Smith I; Ottestad L; Kanis J
Breast Cancer Res; 2006; 8(2):R13. PubMed ID: 16542503
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy.
Clemons MJ; Dranitsaris G; Ooi WS; Yogendran G; Sukovic T; Wong BY; Verma S; Pritchard KI; Trudeau M; Cole DE
J Clin Oncol; 2006 Oct; 24(30):4895-900. PubMed ID: 17001071
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonates and tumor burden.
Mundy GR
J Clin Oncol; 2002 Aug; 20(15):3191-2. PubMed ID: 12149289
[No Abstract] [Full Text] [Related]
17. The evolving role of bone-conserving therapy in patients with breast cancer.
Brufsky AM
Semin Oncol; 2010 Jun; 37 Suppl 1():S12-9. PubMed ID: 20682367
[TBL] [Abstract][Full Text] [Related]
18. Further analysis of the survival benefit of clodronate.
Aragon-Ching JB
Cancer Biol Ther; 2009 Dec; 8(23):2221-2. PubMed ID: 19855155
[TBL] [Abstract][Full Text] [Related]
19. Zoledronic acid for all patients with newly diagnosed multiple myeloma?
Terpos E; Dimopoulos MA
Lancet Oncol; 2011 Aug; 12(8):711-2. PubMed ID: 21771569
[No Abstract] [Full Text] [Related]
20. Can bisphosphonates improve outcomes in patients with newly diagnosed multiple myeloma?
Morgan GJ
Crit Rev Oncol Hematol; 2011 Feb; 77 Suppl 1():S24-30. PubMed ID: 21353177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
